Klencke Barbara
SEC insider (Form 3/4/5 filer). CIK 0001647647. Director at Xencor Inc (XNCR) and 2 other issuers. 9 reported Form 4/5 transactions since Sep 2024; latest on Jun 16, 2026. Located in PASADENA, CA.
Companies Klencke Barbara has filed insider reports for
- Xencor Inc (XNCR): Director
- TScan Therapeutics, Inc. (TCRX): Director
- ALX ONCOLOGY HOLDINGS INC (ALXO): Officer, Chief Medical Officer
Klencke Barbara
CIK: 0001647647
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Jun 16, 2026XNCR
Xencor Inc
AwardDirect10.3K shares- - May 20, 2026TCRX
TScan Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
67K shares- - Apr 16, 2026ALXO
ALX ONCOLOGY HOLDINGS INC
AwardDirectStock option (right to buy)
100K shares- - Mar 3, 2026ALXO
ALX ONCOLOGY HOLDINGS INC
AwardDirectStock option (right to buy)
700K shares- - Sep 17, 2025ALXO
ALX ONCOLOGY HOLDINGS INC
AwardDirectStock option (right to buy)
300K shares- - Jun 30, 2025TCRX
TScan Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
67K shares- - Jun 12, 2025XNCR
Xencor Inc
AwardDirect13.7K shares- - Jan 21, 2025ALXO
ALX ONCOLOGY HOLDINGS INC
AwardDirectStock Option (right to buy)
40.4K shares- - Sep 23, 2024TCRX
TScan Therapeutics, Inc.
PurchaseDirect5K shares at avg. $5.29$26K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 16, 2026 |  XNCR Xencor Inc | Award | 10,302 | - | $0 | Direct |
| May 20, 2026 |  TCRX TScan Therapeutics, Inc. | Award Stock Option (Right to Buy) | 67,000 | - | - | Direct |
| Apr 16, 2026 |  ALXO ALX ONCOLOGY HOLDINGS INC | Award Stock option (right to buy) | 100,000 | - | - | Direct |
| Mar 3, 2026 | ALXO ALX ONCOLOGY HOLDINGS INC | Award Stock option (right to buy) | 700,000 | - | - | Direct |
| Sep 17, 2025 | ALXO ALX ONCOLOGY HOLDINGS INC | Award Stock option (right to buy) | 300,000 | - | - | Direct |
| Jun 30, 2025 | TCRX TScan Therapeutics, Inc. | Award Stock Option (Right to Buy) | 67,000 | - | - | Direct |
| Jun 12, 2025 | XNCR Xencor Inc | Award | 13,686 | - | - | Direct |
| Jan 21, 2025 | ALXO ALX ONCOLOGY HOLDINGS INC | Award Stock Option (right to buy) | 40,400 | - | - | Direct |
| Sep 23, 2024 | TCRX TScan Therapeutics, Inc. | Purchase | 5,000 | $5.29 | $26,450 | Direct |
1-9 of 9 transactions